← Back
Data updated: Mar 10, 2026
FDC LTD
Infectious DiseaseDermatologyCardiovascular
FDC LTD is a generic drug manufacturer focused on Infectious Disease, Dermatology, Cardiovascular. Key products include MOXIFLOXACIN HYDROCHLORIDE.
2008
Since
11
Drugs
-
Trials
87
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LATANOPROST 2026-01-30
Labeling
LATANOPROST 2026-01-30
Labeling
LATANOPROST 2026-01-30
Labeling
FLUCONAZOLE 2026-01-08
OLOPATADINE HYDROCHLORIDE 2026-01-06
CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
LATANOPROST 2025-12-17
PILOCARPINE HYDROCHLORIDE 2025-10-02
DORZOLAMIDE HYDROCHLORIDE 2025-10-01
Labeling
DORZOLAMIDE HYDROCHLORIDE 2025-10-01
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 25%
2 drugs
Dermatology 25%
2 drugs
Cardiovascular 25%
2 drugs
Respiratory 13%
1 drugs
Neurology 13%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular
Active (7)
Discontinued (2)
Company Info
- First Approval
- 2008-04-30
- Latest
- 2026-01-08
- Applications
- 13